GO:0004475 mannose-1-phosphate guanylyltransferase (GTP) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004475 describes the enzymatic activity that converts alpha-D-mannose 1-phosphate and GTP into GDP-alpha-D-mannose and diphosphate, a critical step in GDP-mannose biosynthesis [1,2,6].
• This activity is essential for protein glycosylation, cell wall biosynthesis, and the production of mannose-containing glycoconjugates across bacteria, fungi, and humans [3,4,5,8].
• The enzyme is known by many synonyms, including GDP-mannose pyrophosphorylase, and is often part of a bifunctional complex with phosphomannose isomerase in some organisms.
• In humans, the GMPPA-GMPPB complex maintains GDP-mannose homeostasis, and mutations in GMPPB cause dystroglycanopathies and other glycosylation disorders.
• Researchers study this activity using enzymatic assays, structural biology (cryo-EM), and CRISPR-based knockout or point-mutation models to dissect its role in disease and microbial physiology [3,8].
• Targeting this pathway is of interest for antibiotic development in Mycobacterium tuberculosis and for engineering glycosylation in biotechnological fungi like Trichoderma reesei [1,4].
Description
Mannose-1-phosphate guanylyltransferase (GTP) activity, encoded by GO:0004475, catalyzes the reversible transfer of a guanylyl group from GTP to alpha-D-mannose 1-phosphate, yielding GDP-alpha-D-mannose and diphosphate [1,6]. This reaction is a pivotal step in the de novo synthesis of GDP-mannose, the universal donor for mannosylation reactions in prokaryotes and eukaryotes [2,4]. The enzyme is widely conserved, from bacteria such as Mycobacterium tuberculosis and Leptospira interrogans to fungi like Trichoderma reesei and humans [1,2,4,8]. In bacteria, it supports cell envelope biosynthesis and is a potential drug target [1,3]. In fungi, it influences protein glycosylation and antibiotic susceptibility [3,4]. In humans, the enzyme functions within a heterodimeric complex that regulates GDP-mannose levels, and its dysfunction is linked to congenital muscular dystrophies. Understanding GO:0004475 is therefore central to glycobiology, infectious disease, and inherited metabolic disorders.
mannose-1-phosphate guanylyltransferase (GTP) activity At A Glance
| GO ID | GO:0004475 |
|---|---|
| GO term | mannose-1-phosphate guanylyltransferase (GTP) activity |
| Ontology | molecular_function |
| Synonym | GDP-mannose pyrophosphorylase activity; GTP:alpha-D-mannose-1-phosphate guanylyltransferase activity; guanosine diphosphomannose pyrophosphorylase activity; PIM-GMP |
| Major function | Synthesis of GDP-alpha-D-mannose from alpha-D-mannose 1-phosphate and GTP |
| Reaction | alpha-D-mannose 1-phosphate + GTP = diphosphate + GDP-alpha-D-mannose |
| Organisms | Bacteria, fungi, humans (e.g., Mycobacterium, Leptospira, Trichoderma, Homo sapiens) |
| Human gene | GMPPB (and GMPPA as regulatory subunit) |
| Related diseases | Dystroglycanopathies, glycosylation disorders |
What Is GO:0004475?
GO:0004475 is defined by the Gene Ontology as the catalysis of the reaction: alpha-D-mannose 1-phosphate + GTP = diphosphate + GDP-alpha-D-mannose. In other words, it is the enzyme activity that activates mannose by attaching it to the nucleotide GTP, forming GDP-mannose, a key sugar nucleotide donor. This activity is also known as GDP-mannose pyrophosphorylase or GTP:mannose-1-phosphate guanylyltransferase [1,2,6].
Why Is mannose-1-phosphate guanylyltransferase (GTP) activity Important in Cell Biology?
GO:0004475 is essential because GDP-mannose is a central metabolite for protein glycosylation, cell wall synthesis, and the production of mannoproteins and glycolipids [3,4,5]. In pathogens like Mycobacterium tuberculosis, the enzyme is required for the synthesis of mannose-containing cell envelope components, making it a validated drug target. In fungi, its activity affects protein secretion and antibiotic susceptibility. In humans, the GMPPA-GMPPB complex maintains GDP-mannose homeostasis, and mutations in GMPPB cause severe muscular dystrophies due to defective glycosylation of alpha-dystroglycan. Thus, this activity bridges basic glycobiology with clinical and biotechnological applications.
• Provides GDP-mannose, the donor for all mannosylation reactions in the secretory pathway [4,5].
• Essential for bacterial cell wall and capsule biosynthesis in pathogens like Mycobacterium tuberculosis.
• Required for protein O- and N-glycosylation in fungi, affecting secretion and virulence [3,4].
• Human GMPPB mutations cause dystroglycanopathies, including limb-girdle muscular dystrophy.
• The GMPPA-GMPPB complex regulates GDP-mannose homeostasis, preventing toxic accumulation.
• Target for antibacterial drug discovery, especially against mycobacteria.
• Used in biotechnological production of GDP-mannose and mannose-containing glycans [6,7].
• Model for studying enzyme evolution and bifunctional fusion proteins (e.g., PIM-GMP).
• Relevant to congenital disorders of glycosylation and muscular dystrophies.
• Enables metabolic engineering of glycosylation pathways in industrial fungi.
Molecular Mechanism of mannose-1-phosphate guanylyltransferase (GTP) activity
Substrate binding and catalysis
In simple terms: The enzyme grabs a mannose-1-phosphate and a GTP molecule and joins them together, releasing a diphosphate.
The enzyme binds alpha-D-mannose 1-phosphate and GTP in a sequential ordered mechanism. The reaction proceeds via nucleophilic attack of the phosphate oxygen of mannose-1-phosphate on the alpha-phosphate of GTP, forming GDP-mannose and releasing pyrophosphate [1,6]. This activity has been biochemically characterized in Mycobacterium tuberculosis, where the enzyme shows specificity for GTP and mannose-1-phosphate.
Bifunctional PIM-GMP enzymes
In simple terms: In some organisms, the enzyme is fused with another enzyme that converts fructose-6-phosphate to mannose-6-phosphate, streamlining GDP-mannose production.
In Pyrococcus furiosus and Salmonella enterica, the guanylyltransferase activity resides in a bifunctional protein with phosphomannose isomerase (PMI) activity, known as PIM-GMP. This fusion allows efficient channeling of intermediates for GDP-mannose synthesis [6,7]. The bifunctional enzyme from Pyrococcus furiosus is thermostable and used as a biocatalyst for synthesizing GDP-mannose and other sugar nucleotides.
Human GMPPA-GMPPB complex
In simple terms: In humans, the enzyme works as part of a two-protein machine that keeps GDP-mannose levels balanced.
Human GDP-mannose pyrophosphorylase consists of a catalytic subunit, GMPPB, and a regulatory subunit, GMPPA. Cryo-EM structures revealed that GMPPA binds GDP-mannose and inhibits GMPPB when levels are high, maintaining homeostasis. This allosteric regulation is critical because excess GDP-mannose can be toxic.
Role in glycosylation pathways
In simple terms: The GDP-mannose produced is used to attach mannose sugars to proteins and lipids, which is important for cell recognition and structure.
GDP-mannose generated by GO:0004475 is the substrate for mannosyltransferases in the endoplasmic reticulum and Golgi. In Trichoderma reesei, overexpression of the mpg1 gene increased cellular GDP-mannose levels and protein mannosylation, demonstrating a direct link between enzyme activity and glycosylation capacity [4,5]. In Streptomyces coelicolor, disruption of the GDP-mannose synthesis pathway led to antibiotic hyper-susceptibility, highlighting its role in cell envelope integrity.
Kinetic properties and metal requirements
In simple terms: The enzyme typically needs magnesium ions to work and has specific preferences for its substrates.
Biochemical studies on mycobacterial GDP-mannose pyrophosphorylase showed an absolute requirement for divalent cations, with Mg2+ being optimal. The enzyme follows Michaelis-Menten kinetics with respect to mannose-1-phosphate and GTP. Similar properties were observed for the Leptospira interrogans enzyme, which was functionally characterized and shown to be specific for GTP.
Key Genes Involved in GO:0004475 mannose-1-phosphate guanylyltransferase (GTP) activity
The following genes and proteins are directly associated with mannose-1-phosphate guanylyltransferase (GTP) activity or its regulation across model organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GMPPB (human) | Catalytic subunit of GDP-mannose pyrophosphorylase | Mutations cause dystroglycanopathies; target for glycosylation studies |
| GMPPA (human) | Regulatory subunit of GMPPA-GMPPB complex | Allosteric regulation of GDP-mannose homeostasis; mutations cause alacrima-achalasia-addisonianism |
| mpg1 (Trichoderma reesei) | GTP:mannose-1-phosphate guanyltransferase | Overexpression increases GDP-mannose and protein mannosylation [4,5] |
| rfbM (Mycobacterium tuberculosis) | GDP-mannose pyrophosphorylase | Essential for cell wall biosynthesis; drug target |
| lpg (Leptospira interrogans) | GDP-mannose pyrophosphorylase | Functional characterization; potential vaccine target |
| manC (E. coli) | GDP-mannose pyrophosphorylase | Model for enzymatic studies and metabolic engineering |
| PIM-GMP (Pyrococcus furiosus) | Bifunctional phosphomannose isomerase/GDP-mannose pyrophosphorylase | Thermostable biocatalyst for sugar nucleotide synthesis |
| gmpA (Streptomyces coelicolor) | GDP-mannose pyrophosphorylase | Disruption leads to antibiotic hyper-susceptibility |
| GMPPB (zebrafish) | GDP-mannose pyrophosphorylase | Model for muscular dystrophy |
| GMPPB (mouse) | GDP-mannose pyrophosphorylase | Knockout models for glycosylation disorders |
| algA (Pseudomonas aeruginosa) | Bifunctional PMI-GMP | Alginate biosynthesis; drug target |
| capD (Staphylococcus aureus) | GDP-mannose pyrophosphorylase | Capsule synthesis; virulence |
| GMPPB (Drosophila) | GDP-mannose pyrophosphorylase | Developmental glycosylation studies |
| GMPPB (C. elegans) | GDP-mannose pyrophosphorylase | RNAi models for glycosylation |
| GMPPB (Saccharomyces cerevisiae) | GDP-mannose pyrophosphorylase | Cell wall integrity; mannoprotein synthesis |
| GMPPB (Arabidopsis thaliana) | GDP-mannose pyrophosphorylase | Cell wall polysaccharide biosynthesis |
| GMPPB (Trypanosoma brucei) | GDP-mannose pyrophosphorylase | Glycosylphosphatidylinositol anchor synthesis |
| GMPPB (Leishmania major) | GDP-mannose pyrophosphorylase | Virulence factor; drug target |
How Is mannose-1-phosphate guanylyltransferase (GTP) activity Regulated?
The activity of mannose-1-phosphate guanylyltransferase (GTP) is regulated at multiple levels. In humans, the GMPPA subunit acts as a GDP-mannose sensor that allosterically inhibits GMPPB when GDP-mannose levels are high, maintaining homeostasis. In fungi, expression of the mpg1 gene is induced under conditions requiring high protein glycosylation, and overexpression leads to increased GDP-mannose levels [4,5]. In bacteria, the enzyme may be regulated by feedback inhibition by GDP-mannose, though direct evidence is limited. Additionally, the bifunctional PIM-GMP enzyme in some organisms couples isomerization and guanylyltransferase activities, potentially allowing substrate channeling.
mannose-1-phosphate guanylyltransferase (GTP) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GMPPB | Limb-girdle muscular dystrophy, congenital muscular dystrophy-dystroglycanopathy | Knockout mouse, patient-derived iPSCs, zebrafish |
| GMPPA | Alacrima-achalasia-addisonianism (triple A syndrome) with neurological features | Knockout mouse, cell lines |
| rfbM (M. tuberculosis) | Tuberculosis; cell wall integrity | Conditional knockout in M. tuberculosis, macrophage infection |
| mpg1 (T. reesei) | Protein glycosylation; industrial enzyme production | Overexpression and knockout strains [4,5] |
| gmpA (S. coelicolor) | Antibiotic susceptibility | Deletion mutants, antibiotic sensitivity assays |
Dystroglycanopathies and muscular dystrophies
Mutations in GMPPB, the human gene encoding the catalytic subunit of GDP-mannose pyrophosphorylase, cause a spectrum of dystroglycanopathies characterized by defective glycosylation of alpha-dystroglycan. Patients present with limb-girdle muscular dystrophy, congenital muscular dystrophy, and sometimes brain and eye abnormalities. The GMPPA-GMPPB complex is critical for maintaining GDP-mannose homeostasis, and loss of function leads to reduced mannosylation of alpha-dystroglycan, disrupting its interaction with extracellular matrix proteins.
Infectious diseases and antibiotic targeting
In Mycobacterium tuberculosis, GDP-mannose pyrophosphorylase is essential for the synthesis of mannose-containing cell wall components, including lipoarabinomannan and phosphatidylinositol mannosides. Inhibition of this enzyme weakens the cell wall and increases susceptibility to antibiotics, making it a promising target for anti-tuberculosis drugs. Similarly, in Leptospira interrogans, the enzyme is required for virulence and survival, and its characterization supports vaccine development.
Fungal pathogenesis and antibiotic susceptibility
In Streptomyces coelicolor, disruption of the GDP-mannose synthesis pathway results in antibiotic hyper-susceptibility, indicating that the enzyme is important for intrinsic resistance. In Trichoderma reesei, manipulation of mpg1 affects protein glycosylation, which is relevant for industrial enzyme production and fungal fitness [4,5].
From mannose-1-phosphate guanylyltransferase (GTP) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of GMPPB loss on glycosylation and muscle function? | GMPPB knockout mouse or zebrafish |
| How does GMPPA regulate GMPPB activity? | Point mutations in GMPPA allosteric site, knock-in mice |
| Can small molecules inhibit mycobacterial GDP-mannose pyrophosphorylase? | Recombinant enzyme assays, M. tuberculosis knockout |
| Does overexpression of mpg1 enhance protein mannosylation? | Trichoderma reesei overexpression strains |
| What is the role of GDP-mannose in antibiotic resistance? | Streptomyces coelicolor deletion mutants |
| How does the bifunctional PIM-GMP enzyme channel substrates? | Structural studies, site-directed mutagenesis |
How to Study the mannose-1-phosphate guanylyltransferase (GTP) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay with radioactive GTP | Guanylyltransferase activity | Kinetic characterization, inhibitor screening |
| Cryo-EM | 3D structure of protein complexes | Understanding allosteric regulation |
| Lectin blotting | Protein mannosylation levels | Assessing glycosylation changes |
| Mass spectrometry | Glycan structures and site occupancy | Detailed glycosylation analysis |
| CRISPR knockout | Gene function in cells/organisms | Disease modeling |
| Site-directed mutagenesis | Role of specific residues | Mechanistic studies |
| Antibiotic sensitivity assays | Cell wall integrity | Drug target validation |
| Immunoblotting for alpha-dystroglycan | Glycosylation status | Diagnosis of dystroglycanopathies |
Enzymatic activity assays
The guanylyltransferase activity can be measured using coupled enzyme assays that monitor the formation of GDP-mannose or the release of pyrophosphate. Radioactive or fluorescently labeled substrates are commonly used. For example, the mycobacterial enzyme was purified and its kinetics characterized using [3H]-GDP-mannose. High-throughput assays are suitable for inhibitor screening.
Structural biology (cryo-EM and X-ray crystallography)
Cryo-EM structures of the human GMPPA-GMPPB complex revealed the architecture and allosteric regulation by GDP-mannose. X-ray crystallography of bacterial enzymes has provided insights into substrate binding and catalytic mechanism [1,2]. These methods are essential for structure-guided drug design.
Glycosylation analysis
Changes in protein mannosylation can be assessed by lectin blotting, mass spectrometry of glycans, or metabolic labeling with radioactive mannose. Overexpression of mpg1 in Trichoderma reesei increased mannosylation of secreted proteins, as shown by lectin binding [4,5]. In human cells, defective alpha-dystroglycan glycosylation can be detected by immunoblotting with specific antibodies.
Genetic manipulation and phenotypic analysis
Knockout, knockdown, or overexpression of genes encoding the enzyme are used to study its cellular roles. In Streptomyces coelicolor, deletion of gmpA led to antibiotic hyper-susceptibility. In zebrafish, morpholino knockdown of gmppb caused muscular dystrophy phenotypes. These models link enzyme activity to organismal phenotypes.
How CRISPR Can Be Used to Study GO:0004475 mannose-1-phosphate guanylyltransferase (GTP) activity
Knockout
CRISPR-Cas9 knockout of GMPPB or its orthologs is used to create cell and animal models of glycosylation disorders. For example, knockout of gmppb in zebrafish recapitulates muscular dystrophy phenotypes. In bacteria, CRISPR interference can be used to knock down rfbM to study cell wall defects. These models help establish causality between enzyme loss and disease.
Point Mutation
Point mutations identified in patients with dystroglycanopathies can be introduced into GMPPB using CRISPR base editing or homology-directed repair. Such models allow study of specific missense mutations on enzyme activity and complex assembly. For example, mutations in the GMPPA allosteric site can be mimicked to understand regulation.
Knock-in
Knock-in of tagged versions of GMPPB (e.g., GFP or FLAG) enables live-cell imaging and proteomic analysis of the enzyme complex. Knock-in of disease-associated mutations into the endogenous locus provides physiologically relevant models. In fungi, knock-in of mpg1 under a strong promoter can enhance glycosylation.
Overexpression
CRISPR activation (CRISPRa) or plasmid-based overexpression of mpg1 in Trichoderma reesei increased GDP-mannose levels and protein mannosylation. Overexpression of GMPPB in human cells can be used to study the effects of excess GDP-mannose and complex formation. These approaches are valuable for biotechnological applications.
How EDITGENE Supports mannose-1-phosphate guanylyltransferase (GTP) activity Research
Researchers studying mannose-1-phosphate guanylyltransferase (GTP) activity-related genes often need to determine whether a candidate gene is causally involved in glycosylation, cell wall integrity, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and drug discovery.
Contact EDITGENE today to design your custom CRISPR model for mannose-1-phosphate guanylyltransferase (GTP) activity research.
Frequently Asked Questions About mannose-1-phosphate guanylyltransferase (GTP) activity
What is mannose-1-phosphate guanylyltransferase (GTP) activity?
It is the enzyme activity defined by GO:0004475 that catalyzes the conversion of alpha-D-mannose 1-phosphate and GTP to GDP-alpha-D-mannose and diphosphate, a key step in GDP-mannose synthesis [1,6].
What genes are involved in mannose-1-phosphate guanylyltransferase (GTP) activity?
Key genes include GMPPB (human catalytic subunit), GMPPA (human regulatory subunit), mpg1 (Trichoderma reesei), rfbM (Mycobacterium tuberculosis), and manC (E. coli) [1,4,8].
What is the reaction catalyzed by GO:0004475?
The reaction is: alpha-D-mannose 1-phosphate + GTP = diphosphate + GDP-alpha-D-mannose [1,2].
What are the synonyms for mannose-1-phosphate guanylyltransferase (GTP) activity?
Common synonyms include GDP-mannose pyrophosphorylase, GTP:alpha-D-mannose-1-phosphate guanylyltransferase, and guanosine diphosphomannose pyrophosphorylase [1,6].
How is mannose-1-phosphate guanylyltransferase (GTP) activity regulated in humans?
In humans, the GMPPA subunit senses GDP-mannose levels and allosterically inhibits the catalytic GMPPB subunit to maintain homeostasis.
What diseases are associated with mutations in GMPPB?
Mutations in GMPPB cause dystroglycanopathies, including limb-girdle muscular dystrophy and congenital muscular dystrophy with brain and eye abnormalities.
How can I study mannose-1-phosphate guanylyltransferase (GTP) activity in the lab?
You can use enzymatic assays with radioactive GTP, cryo-EM for structure, lectin blotting for glycosylation, and CRISPR knockout models [1,4,8].
Is mannose-1-phosphate guanylyltransferase a drug target?
Yes, in Mycobacterium tuberculosis the enzyme is essential for cell wall synthesis and is a target for anti-tuberculosis drugs.
What is the role of GDP-mannose in cells?
GDP-mannose is the donor substrate for mannosylation of proteins and lipids, important for cell wall integrity, protein folding, and cell signaling [4,5].
Can EDITGENE help create CRISPR models for this pathway?
Yes, EDITGENE provides knockout, point mutation, knock-in, overexpression, and library screening services for genes related to mannose-1-phosphate guanylyltransferase activity.
Conclusion
Mannose-1-phosphate guanylyltransferase (GTP) activity (GO:0004475) is a fundamental enzymatic step in GDP-mannose biosynthesis, impacting glycosylation, cell wall integrity, and human disease. Its conservation across bacteria, fungi, and humans makes it a versatile model for studying enzyme mechanism, allosteric regulation, and drug discovery. Continued research using CRISPR models and structural biology will further illuminate its roles and therapeutic potential.
References
- 1. Ning B et al.. 1999. Purification and properties of mycobacterial GDP-mannose pyrophosphorylase.. Arch Biochem Biophys 362(2):339-45 PMID: 9989944
- 2. Asención Diez MD et al.. 2010. Functional characterization of GDP-mannose pyrophosphorylase from Leptospira interrogans serovar Copenhageni.. Arch Microbiol 192(2):103-14 PMID: 20035319
- 3. Howlett R et al.. 2018. Disruption of the GDP-mannose synthesis pathway in Streptomyces coelicolor results in antibiotic hyper-susceptible phenotypes.. Microbiology (Reading) 164(4):614-624 PMID: 29493491
- 4. Zakrzewska A et al.. 2003. Overexpression of the gene encoding GTP:mannose-1-phosphate guanyltransferase, mpg1, increases cellular GDP-mannose levels and protein mannosylation in Trichoderma reesei.. Appl Environ Microbiol 69(8):4383-9 PMID: 12902219
- 5. Kruszewska JS et al.. 1998. Isolation of a Trichoderma reesei cDNA encoding GTP: a-D-mannose-1-phosphate guanyltransferase involved in early steps of protein glycosylation.. Curr Genet 33(6):445-50 PMID: 9644208
- 6. Elling L et al.. 1996. Expression, purification and characterization of recombinant phosphomannomutase and GDP-alpha-D-mannose pyrophosphorylase from Salmonella enterica, group B, for the synthesis of GDP-alpha-D-mannose from D-mannose.. Glycobiology 6(6):591-7 PMID: 8922954
- 7. Mizanur RM et al.. 2009. Phosphomannose isomerase/GDP-mannose pyrophosphorylase from Pyrococcus furiosus: a thermostable biocatalyst for the synthesis of guanidinediphosphate-activated and mannose-containing sugar nucleotides.. Org Biomol Chem 7(10):2135-9 PMID: 19421452
- 8. Zheng L et al.. 2021. Cryo-EM structures of human GMPPA-GMPPB complex reveal how cells maintain GDP-mannose homeostasis.. Nat Struct Mol Biol 28(5):1-12 PMID: 33986552
